Acinetobacter Baumannii
Download the word version here
Morphology | Rod-shaped gram-negative bacteria. |
---|---|
Disease
|
Pneumonia, urinary tract infections, wound infections, soft tissue infections, secondary meningitis, nosocomial infections. |
Zoonosis
|
None. |
Host Range | Humans. |
---|---|
Modes of Transmission
|
Poses very little risk to healthy individuals. People who have weakened immune systems
are at risk. Can be spread to susceptible persons by person-to-person contact with
contaminated surfaces.
|
Signs and Symptoms |
Causes a variety of diseases ranging from pneumonia to serious blood or wound infections. |
Infectious Dose | unknown |
Incubation Period | unknown |
Prophylaxis |
None available.
|
---|---|
Vaccines |
None available.
|
Treatment | Treatment with imipenem or meropenem, but a steady rise in carbapenem resistance has been reported. Consequently, treatment methods often fall on polymyxins, such as colistin. |
Surveillance |
Monitor for symptoms.
|
MSU Requirements
|
Report any exposures.
|
Laboratory Acquired Infections (LAIs) | None have been reported.
|
---|---|
Sources |
Aquatic environments, sputum, respiratory secretions, wounds, and urine. Cultures,
frozen stocks, other samples described in IBC protocol.
|
Canadian MSDS
|
http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/index-eng.php |
---|---|
BMBL
|
https://www.cdc.gov/labs/bmbl/?CDC_AAref_Val=https://www.cdc.gov/labs/BMBL.html |
CDC
|
|
NIH Guidlines
|
Risk Group 2
|
Agents that are associated with human disease which is rarely serious and for which preventive or therapeutic interventions are often available. |
---|---|
BSL2
|
For all procedures involving suspected or known infectious specimen or cultures.
|
ABSL2
|
For all procedures utilizing infected animals.
|
Small
|
Notify others working in the lab. Remove PPE and don new PPE. Cover area of the spill
with absorbent material and add fresh 1:10 bleach:water. Allow 20 munutes (or as directed)
of contact time. After 20 minutes, cleanup and dispose of materials.
|
---|---|
Large
|
|
Mucous membrane
|
Flush eyes, mouth, or nose for 5 minutes at eyewash station.
|
---|---|
Other Exposures
|
Wash area with soap and water for 5 minutes.
|
Reporting |
Immediately report incident to supervisor, complete a First Report of Injury form, and submit to Safety and Risk Management.
|
Medical Follow-up
|
During business hours: Bridger Occupational Health 3406 Laramie Drive. Weekdays 8am -6pm. Weekends 9am-5pm
After business hours: Bozeman Deaconess Hospital Emergency Room 915 Highland Blvd Bozeman, MT |
Disinfection |
Susceptible to 1:10 bleach:water, 70 % ethanol, and 2 % formaldehyde, accelerated
hydrogen peroxide
|
---|---|
Inactivation |
Inactivated by moist heat (15 minutes at 121oC) and dry heat (1 hour at 160-170oC).
|
Survival Outside Host
|
Survives in the environment for long periods of time.
|
Minimum PPE Requirements
|
Lab coat, disposable gloves, safety glasses, closed toed shoes, long pants
|
---|---|
Additional Precautions
|
Additioanl PPE may be required depending on lab specific SOPs and IBC Protocol. |